EDGAR Filing Documents for 0001193125-17-085007

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-17-085007

Filing Date

2017-03-16

Accepted

2017-03-16 12:01:32

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3	d352764ds3.htm	S-3	235238
2	EX-4.2	d352764dex42.htm	EX-4.2	269316
3	EX-5.1	d352764dex51.htm	EX-5.1	23609
4	EX-12.1	d352764dex121.htm	EX-12.1	26520
5	EX-23.2	d352764dex232.htm	EX-23.2	1365
6	EX-25.1	d352764dex251.htm	EX-25.1	129668
7	GRAPHIC	g352764document2.jpg	GRAPHIC	5294
8	GRAPHIC	g352764g40y10.jpg	GRAPHIC	61533
	Complete submission text file	0001193125-17-085007.txt		778987

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139

Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626

Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)